Atlas Trials

Standard- and Micro-Dose rhBMP-2 for Implant Stability, Marginal Bone Loss, and Postoperative Sequelae: A Double-Blind Randomized Controlled Trial

Clinical trial NCT07696299 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07696299
Sponsor
University of Baghdad
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Tooth Loss / RehabilitationDental ImplantOsseo-Integrated Implants
Start date
2026-12-01
Primary completion
2028-03-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.